Advertisement

ADVERTISEMENT

Maria Asimopoulos

Headshot of Maria Zlotorzynska, PhD, MPH, Centers for Disease Control and Prevention
Interview
Residential Social Vulnerability Linked With Risk of COVID-19 Infection Among HCPs
08/02/2023
Maria Asimopoulos
Maria Zlotorzynska, PhD, MPH, health scientist, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, offers insight into how health care workers' residential locations can impact their vulnerability to...
Maria Zlotorzynska, PhD, MPH, health scientist, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, offers insight into how health care workers' residential locations can impact their vulnerability to...
Maria Zlotorzynska, PhD, MPH,...
08/02/2023
Integrated Healthcare Executive
News
Remdesivir Cost-Effective for Treating Hospitalized Patients With COVID-19
07/31/2023
Maria Asimopoulos
Researchers conducted an analysis of hospitalized patients with COVID-19 to compare the cost-effectiveness of remdesivir plus standard care vs standard care alone. 
Researchers conducted an analysis of hospitalized patients with COVID-19 to compare the cost-effectiveness of remdesivir plus standard care vs standard care alone. 
Researchers conducted an...
07/31/2023
Integrated Healthcare Executive
Headshot of Marco Antonio Catussi Paschoalotto, PhD
Interview
Revisiting Health Systems Resilience After the Pandemic
07/26/2023
Maria Asimopoulos
"To properly respond to crises, it is necessary to have all parts of the health system resilience framework work together," said Marco Antonio Catussi Paschoalotto, PhD, assistant professor, School of Economics and Management, University of...
"To properly respond to crises, it is necessary to have all parts of the health system resilience framework work together," said Marco Antonio Catussi Paschoalotto, PhD, assistant professor, School of Economics and Management, University of...
"To properly respond to crises,...
07/26/2023
Integrated Healthcare Executive
News
Injectable PrEP Overall Acceptable, Preferred for HIV Prevention
07/15/2023
Maria Asimopoulos
“Given overall acceptability, injectable PrEP should be included as part of a menu of prevention options, allowing end-users to select the modality that suits their preferences, needs and lifestyle,” researchers advised.
“Given overall acceptability, injectable PrEP should be included as part of a menu of prevention options, allowing end-users to select the modality that suits their preferences, needs and lifestyle,” researchers advised.
“Given overall acceptability,...
07/15/2023
First Report Managed Care
Headshot of Rebecca Perkins, Boston University
Interview
Health Care Workers Identify Causes of Burnout, Potential Solutions
06/30/2023
Maria Asimopoulos
"Improving the situation for health care workers so they have sufficient resources and support to provide the best care for patients will decrease health care worker attrition," says Rebecca Perkins, MD, MSc, professor of obstetrics and...
"Improving the situation for health care workers so they have sufficient resources and support to provide the best care for patients will decrease health care worker attrition," says Rebecca Perkins, MD, MSc, professor of obstetrics and...
"Improving the situation for...
06/30/2023
Integrated Healthcare Executive
Headshot of Razel Milo, University of San Diego
Interview
Addressing COVID-19 Vaccination Barriers Among Hispanic, Latino Individuals
06/29/2023
Maria Asimopoulos
Razel Milo, PhD, MSN, DNP, associate professor, University of San Diego, offers insight into barriers against COVID-19 vaccination in Hispanic and Latino populations and recommendations for more effective outreach efforts.  
Razel Milo, PhD, MSN, DNP, associate professor, University of San Diego, offers insight into barriers against COVID-19 vaccination in Hispanic and Latino populations and recommendations for more effective outreach efforts.  
Razel Milo, PhD, MSN, DNP,...
06/29/2023
Integrated Healthcare Executive
Conference Coverage
Significant Number of Solid Tumor Drug Approvals Added Complexity to Existing Regimens
06/08/2023
Maria Asimopoulos
A significant portion of drug approvals for nonhematologic solid cancers in the last 12 years were for indications which added to existing regimens, which could increase costs and exposure to side effects, researchers said.
A significant portion of drug approvals for nonhematologic solid cancers in the last 12 years were for indications which added to existing regimens, which could increase costs and exposure to side effects, researchers said.
A significant portion of drug...
06/08/2023
First Report Managed Care
Conference Coverage
FDA Oncology Approvals Commonly Involve Surrogate Endpoints, Analysis Shows
06/02/2023
Maria Asimopoulos
In an updated analysis presented at the 2023 ASCO Annual Meeting, researchers examined the frequency with which surrogate endpoints were used to support oncology approvals from 2006 to 2022.
In an updated analysis presented at the 2023 ASCO Annual Meeting, researchers examined the frequency with which surrogate endpoints were used to support oncology approvals from 2006 to 2022.
In an updated analysis presented...
06/02/2023
First Report Managed Care
Conference Coverage
Medicare Telehealth Utilization Rates Lowest in Regions Lacking Access to Specialized Cancer Care
06/02/2023
Maria Asimopoulos
"Advocacy and policy efforts directed towards increasing access to telehealth can ensure equitable and timely access to specialized cancer care in these regions of need," researchers said.
"Advocacy and policy efforts directed towards increasing access to telehealth can ensure equitable and timely access to specialized cancer care in these regions of need," researchers said.
"Advocacy and policy efforts...
06/02/2023
First Report Managed Care

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

September 18 ⁠–⁠ September 20
September 20 ⁠–⁠ September 22
September 21 ⁠–⁠ September 22
AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use